Total Payments
$2,161
2024 Payments
$237.53
Companies
17
Transactions
68
Medicare Patients
24,119
Medicare Billing
$5.7M
Payment Breakdown by Category
Food & Beverage$1,724 (79.8%)
Other$437.19 (20.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,724 | 64 | 79.8% |
| Entertainment | $437.19 | 4 | 20.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| OPTOS, INC. | $523.11 | 7 | $0 (2018) |
| Genentech USA, Inc. | $509.30 | 17 | $0 (2024) |
| Alimera Sciences, Inc. | $251.52 | 10 | $0 (2018) |
| Astellas Pharma US Inc | $120.94 | 1 | $0 (2023) |
| Bausch & Lomb, a division of Bausch Health US, LLC | $104.90 | 7 | $0 (2021) |
| Alcon Research Ltd | $100.45 | 1 | $0 (2017) |
| Alcon Vision LLC | $93.99 | 2 | $0 (2024) |
| Biogen, Inc. | $80.98 | 3 | $0 (2023) |
| Apellis Pharmaceuticals, Inc. | $75.59 | 3 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $63.17 | 4 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $237.53 | 11 | Genentech USA, Inc. ($135.97) |
| 2023 | $351.37 | 10 | Astellas Pharma US Inc ($120.94) |
| 2022 | $217.72 | 6 | Genentech USA, Inc. ($132.59) |
| 2021 | $156.02 | 4 | Genentech USA, Inc. ($111.69) |
| 2020 | $81.10 | 5 | Aerie Pharmaceuticals, Inc. ($37.66) |
| 2019 | $78.50 | 5 | Novartis Pharmaceuticals Corporation ($30.12) |
| 2018 | $365.27 | 15 | Alimera Sciences, Inc. ($151.19) |
| 2017 | $673.82 | 12 | Optos, Inc. ($437.19) |
All Payment Transactions
68 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $23.84 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
| 11/14/2024 | Genentech USA, Inc. | Susvimo (Drug) | Food and Beverage | In-kind items and services | $19.96 | General |
| Category: Immunology and Ophthalmology | ||||||
| 11/12/2024 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | In-kind items and services | $29.40 | General |
| Category: Ophthalmology | ||||||
| 10/10/2024 | Genentech USA, Inc. | Susvimo (Drug) | Food and Beverage | In-kind items and services | $17.59 | General |
| Category: Immunology and Ophthalmology | ||||||
| 09/24/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $25.85 | General |
| Category: Immunology and Ophthalmology | ||||||
| 09/05/2024 | Genentech USA, Inc. | Susvimo (Drug), Vabysmo | Food and Beverage | In-kind items and services | $12.77 | General |
| Category: Immunology and Ophthalmology | ||||||
| 08/15/2024 | Alcon Vision LLC | Constellation (Device) | Food and Beverage | In-kind items and services | $48.32 | General |
| Category: Ophthalmology | ||||||
| 08/08/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $24.81 | General |
| Category: Immunology and Ophthalmology | ||||||
| 07/15/2024 | Genentech USA, Inc. | Susvimo (Drug) | Food and Beverage | In-kind items and services | $8.50 | General |
| Category: Immunology and Ophthalmology | ||||||
| 06/20/2024 | Genentech USA, Inc. | Susvimo (Drug), Vabysmo | Food and Beverage | In-kind items and services | $6.29 | General |
| Category: Immunology and Ophthalmology | ||||||
| 04/25/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $20.20 | General |
| Category: Immunology and Ophthalmology | ||||||
| 12/13/2023 | Genentech USA, Inc. | Susvimo (Drug), Vabysmo | Food and Beverage | In-kind items and services | $20.35 | General |
| Category: Immunology and Ophthalmology | ||||||
| 11/16/2023 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $27.62 | General |
| Category: Immunology and Ophthalmology | ||||||
| 07/11/2023 | Astellas Pharma US Inc | — | Food and Beverage | In-kind items and services | $120.94 | General |
| 05/11/2023 | Genentech USA, Inc. | Susvimo (Drug), Vabysmo | Food and Beverage | In-kind items and services | $21.56 | General |
| Category: Immunology and Ophthalmology | ||||||
| 04/26/2023 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $21.48 | General |
| Category: Immunology and Ophthalmology | ||||||
| 03/22/2023 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | Cash or cash equivalent | $24.41 | General |
| Category: Ophthalmology | ||||||
| 02/02/2023 | Alcon Vision LLC | Constellation (Device) | Food and Beverage | In-kind items and services | $45.67 | General |
| Category: Ophthalmology | ||||||
| 01/26/2023 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $21.10 | General |
| Category: Immunology and Ophthalmology | ||||||
| 01/25/2023 | Biogen, Inc. | — | Food and Beverage | In-kind items and services | $26.46 | General |
| 01/11/2023 | Apellis Pharmaceuticals, Inc. | — | Food and Beverage | Cash or cash equivalent | $21.78 | General |
| 11/02/2022 | Biogen, Inc. | — | Food and Beverage | In-kind items and services | $25.57 | General |
| 09/12/2022 | Biogen, Inc. | — | Food and Beverage | In-kind items and services | $28.95 | General |
| 08/26/2022 | Bausch & Lomb Americas Inc. | XERESE (Drug) | Food and Beverage | In-kind items and services | $16.58 | General |
| Category: Dermatology | ||||||
| 08/18/2022 | Genentech USA, Inc. | — | Food and Beverage | In-kind items and services | $16.11 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 5,451 | 19,276 | $5.9M | $2.0M |
| 2022 | 19 | 6,076 | 13,766 | $4.7M | $1.3M |
| 2021 | 20 | 6,637 | 23,280 | $4.9M | $1.3M |
| 2020 | 22 | 5,955 | 23,271 | $4.1M | $1.0M |
Total Patients
24,119
Total Services
79,593
Medicare Billing
$5.7M
Procedure Codes
78
All Medicare Procedures & Services
78 procedure records from CMS Medicare Utilization — Page 3 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 201 | 267 | $22,695 | $9,863 | 43.5% |
| 92014 | Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits | Office | 2021 | 154 | 154 | $32,340 | $7,691 | 23.8% |
| 92012 | Eye and medical examination for diagnosis and treatment, established patient | Office | 2021 | 131 | 131 | $20,960 | $3,552 | 16.9% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 32 | 32 | $6,560 | $2,604 | 39.7% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 11 | 11 | $4,345 | $1,583 | 36.4% |
| 76512 | Ultrasound of eye disease, growth, or structure | Office | 2021 | 35 | 36 | $8,280 | $1,258 | 15.2% |
| 67028 | Injection of drug into eye | Office | 2020 | 769 | 2,749 | $2.1M | $230,489 | 10.8% |
| J0178 | Injection, aflibercept, 1 mg | Office | 2020 | 29 | 229 | $263,350 | $170,257 | 64.7% |
| J7999 | Compounded drug, not otherwise classified | Office | 2020 | 735 | 3,384 | $373,980 | $136,776 | 36.6% |
| 92235 | Imaging of blood vessels in back of eye using fluorescein dye | Office | 2020 | 638 | 1,362 | $251,970 | $96,241 | 38.2% |
| J3396 | Injection, verteporfin, 0.1 mg | Office | 2020 | 63 | 9,750 | $146,250 | $86,414 | 59.1% |
| 92012 | Eye and medical examination for diagnosis and treatment, established patient | Office | 2020 | 830 | 983 | $157,280 | $55,284 | 35.1% |
| 92014 | Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits | Office | 2020 | 543 | 546 | $114,660 | $48,698 | 42.5% |
| 92250 | Photography of the retina | Office | 2020 | 794 | 1,756 | $219,500 | $48,016 | 21.9% |
| 92134 | Diagnostic imaging of retina | Office | 2020 | 896 | 1,780 | $169,100 | $47,383 | 28.0% |
| 67041 | Removal of membrane from the retina | Facility | 2020 | 40 | 40 | $99,600 | $35,487 | 35.6% |
| 67221 | Destruction of vascular growth between retina and sclera | Office | 2020 | 62 | 64 | $39,360 | $13,429 | 34.1% |
| 67108 | Repair of detached retina and drainage of eye fluid between lens and retina | Facility | 2020 | 13 | 13 | $40,820 | $11,811 | 28.9% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 96 | 96 | $28,800 | $10,519 | 36.5% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Office | 2020 | 59 | 59 | $23,305 | $9,349 | 40.1% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 82 | 86 | $16,340 | $6,046 | 37.0% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 108 | 116 | $15,080 | $5,062 | 33.6% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Office | 2020 | 95 | 151 | $12,835 | $4,216 | 32.9% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 35 | 35 | $9,625 | $3,678 | 38.2% |
| 92004 | Eye and medical examination for diagnosis and treatment, new patient, 1 or more visits | Office | 2020 | 18 | 18 | $4,680 | $1,648 | 35.2% |
About David Chacko, M.D., PH.D
David Chacko, M.D., PH.D is a Ophthalmology healthcare provider based in Wichita, Kansas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/08/2006. The National Provider Identifier (NPI) number assigned to this provider is 1922167303.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, David Chacko, M.D., PH.D has received a total of $2,161 in payments from pharmaceutical and medical device companies, with $237.53 received in 2024. These payments were reported across 68 transactions from 17 companies. The most common payment nature is "Food and Beverage" ($1,724).
As a Medicare-enrolled provider, Chacko has provided services to 24,119 Medicare beneficiaries, totaling 79,593 services with total Medicare billing of $5.7M. Data is available for 4 years (2020–2023), covering 78 distinct procedure/service records.
Ad
Practice Information
- Specialty Ophthalmology
- Other Specialties Retina Specialist
- Location Wichita, KS
- Active Since 12/08/2006
- Last Updated 01/29/2018
- Taxonomy Code 207W00000X
- Entity Type Individual
- NPI Number 1922167303
Products in Payments
- California (Device) $437.19
- Vabysmo (Drug) $141.06
- VISUDYNE (Drug) $118.93
- SUSVIMO (Drug) $116.48
- Susvimo (Drug) $107.02
- Constellation (Device) $93.99
- Monaco (Device) $85.92
- Iluvien (Biological) $59.61
- Syfovre (Drug) $53.81
- OZURDEX (Drug) $48.87
- XIIDRA (Drug) $42.95
- Iluvien (Drug) $40.72
- BEOVU (Drug) $36.22
- ACTHAR (Biological) $32.17
- PURIFIED CORTROPHIN GEL (Drug) $23.84
- YUTIQ (Drug) $21.28
- rhopressa (Drug) $19.13
- rocklatan (Drug) $18.53
- Lucentis (Biological) $16.94
- XERESE (Drug) $16.58
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Ophthalmology Doctors in Wichita
Dr. Anita Campbell, M.d, M.D
Ophthalmology — Payments: $152,349
Ophthalmology $152,349
Alan Hromas, Md, MD
Ophthalmology — Payments: $32,953
Ophthalmology $32,953
Dr. Paul Weishaar, M.d, M.D
Ophthalmology — Payments: $16,696
Ophthalmology $16,696
Dr. Michael Varenhorst, M.d, M.D
Ophthalmology — Payments: $10,247
Ophthalmology $10,247
Michele Riggins, Md, MD
Ophthalmology — Payments: $9,023
Ophthalmology $9,023
Dr. Reena Patel
Ophthalmology — Payments: $7,811
Ophthalmology $7,811